Top

Indian Journal of Hematology and Blood Transfusion

Published in:

15-08-2023 | Acute Promyelocytic Leukemia | Correspondence

The Frequency, Clinico-Hematological Features, and Outcome of Acute Promyelocytic Leukemia with Variant RARA Rearrangements: A Single Center Experience from India

Authors: Anjali Gupta, Sreejesh Sreedharanunni, Charanpreet Singh, Praveen Sharma, Anshu Anshu, Shailja Rathore, Anand Balakrishnan, Jogeshwar Binota, Shano Naseem, Man Updesh Singh Sachdeva, Alka Khadwal, Arihant Jain, Reena Das, Pankaj Malhotra

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 1/2024

Excerpt

Dear Editor, …

Available only for authorised users

Zhang X, Sun J, Yu W, Jin J (2021) Current views on the genetic landscape and management of variant acute promyelocytic leukemia. Biomark Res 9:33. https://doi.org/10.1186/s40364-021-00284-xCrossRefPubMedPubMedCentral

Rabade N, Raval G, Chaudhary S, Subramanian PG, Kodgule R, Joshi S et al (2018) Molecular heterogeneity in acute promyelocytic leukemia-a single center experience from India. Mediterr J Hematol Infect Dis 10:e2018002CrossRefPubMedPubMedCentral

Sobas M, Talarn-Forcadell MC, Martínez-Cuadrón D, Escoda L, García-Pérez MJ, Mariz J et al (2020) PLZF-RARα, NPM1-RARα, and other acute promyelocytic leukemia variants: the PETHEMA registry experience and systematic literature review. Cancers 12:E1313CrossRef

Grimwade D, Biondi A, Mozziconacci MJ, Hagemeijer A, Berger R, Neat M, et al (2000) Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European working party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d’hematologie cellulaire, UK cancer cytogenetics group and BIOMED 1 European community-concerted action. “Molecular cytogenetic diagnosis in haematological malignancies”. Blood 96:1297–308

Sainty D, Liso V, Cantù-Rajnoldi A, Head D, Mozziconacci MJ, Arnoulet C et al (2000) A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements. Blood 96:1287–1296PubMed

Kluk MJ, Abo RP, Brown RD, Kuo FC, Dal Cin P, Pozdnyakova O et al (2015) Myeloid neoplasm demonstrating a STAT5B-RARA rearrangement and genetic alterations associated with all-trans retinoic acid resistance identified by a custom next-generation sequencing assay. Cold Spring Harb Mol Case Stud 1:a000307CrossRefPubMedPubMedCentral

Title: The Frequency, Clinico-Hematological Features, and Outcome of Acute Promyelocytic Leukemia with Variant RARA Rearrangements: A Single Center Experience from India
Authors: Anjali Gupta
Sreejesh Sreedharanunni
Charanpreet Singh
Praveen Sharma
Anshu Anshu
Shailja Rathore
Anand Balakrishnan
Jogeshwar Binota
Shano Naseem
Man Updesh Singh Sachdeva
Alka Khadwal
Arihant Jain
Reena Das
Pankaj Malhotra
Publication date: 15-08-2023
Publisher: Springer India
Keyword: Acute Promyelocytic Leukemia
Published in: Indian Journal of Hematology and Blood Transfusion / Issue 1/2024
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-023-01685-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

CMV Infection Post Allogeneic Hematopoietic Stem Cell Transplantation in a Resource Limited Country

Potential Clinical Role of LncRNA miR503HG in Multiple Myeloma and its Effect on the Proliferation and Adhesion of Myeloma Cells

Combining Low-Dose Rituximab and Bortezomib as Immunosuppressive Therapy for Acquired Hemophilia A: 6 Case Series

Comparison Pharmacokinetic Dosing Tools in Hemophilia A Children

The First Report of Three Glucose-6-Phosphate Dehydrogenase (G6PD) Variants: Mediterranean, Orissa and Kalyan-Kerala from Northeast India

Metformin as a Fetal Hemoglobin Inducer in Non-transfusion Dependent Thalassemia Patients

Keynote webinar | Spotlight on antibody–drug conjugates in cancer